FindTrial
Sign In

Exploration of the Feasibility of Rapid Immunohistochemical Staining for Pleural and Ascitic Fluids

Exploration of the Feasibility of Rapid Immunohistochemical Staining for Pleural and Ascitic Fluids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109448
Enrollment
Unknown
Registered
2025-09-18
Start date
2025-09-20
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

??Lung Adenocarcinoma?

Interventions

Gold Standard:Standard paraffin IHC
Index test:A Rapid Immunohistochemical Staining System for Serous Effusion Cytology

Sponsors

PEKING UNIVERSITY SHENZHEN HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Complete clinical information; 2. Cases requiring immunohistochemical analysis due to unclear cytopathological diagnosis, with consensus reached by two senior pathologists.

Exclusion criteria

Exclusion criteria: 1. Non-malignant pleural or ascitic fluid cases; 2. Cases where malignancy is definitively confirmed by routine HE staining.

Design outcomes

Primary

MeasureTime frame
Concordance;Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactJunLiang Tan

PEKING UNIVERSITY SHENZHEN HOSPITAL

648605854@qq.com+86 769 8515 1187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026